ÂÜÀòÂÒÂ×

Jeffrey Conroy serves as Chief Scientific Officer for OmniSeq. He oversees the scientific functions of OmniSeq, including Research and Development (R&D), Bioinformatics and Information Technology. He leads business development activities with key industry and pharmaceutical partners, and oversees the development and implementation of advanced diagnostic tests from target design through analytical validation. Prior to joining OmniSeq, Jeff spent three years as Director of Genomic Technologies in the Center for Personalized Medicine at Roswell Park Comprehensive Cancer Center.